Tolterodine in the treatment of overactive bladder: analysis of the pooled phase II efficacy and safety data - oxybutynin versus propantheline versus placebo

By Larsson G.   Hallen B.   Nilvebrant L.  

Urology, Vol. 53, Iss. 5, 1999-05 ,pp. : 990-998

Elsevier

Access to resources Recommend Favorite

Evaluation of a new once-daily formulation of oxybutynin for the treatment of urinary urge incontinence

By Gleason D.M.   Susset J.   White C.   Munoz D.R.   Sand P.K.   DITROPAN XL STUDY GROUP  

Urology, Vol. 54, Iss. 3, 1999-09 ,pp. : 420-423

Elsevier

Access to resources Recommend Favorite

Efficacy of tolterodine in preventing urge incontinence immediately after prostatectomy

By Mitropoulos Dionisios   Papadoukakis Stefanos   Zervas Anastasios   Alamanis Christos   Giannopoulos Aris  

International Urology and Nephrology, Vol. 38, Iss. 2, 2006-06 ,pp. : 263-268

Springer Publishing Company

Access to resources Recommend Favorite

Health-related quality of life of Japanese patients with overactive bladder treated with extended-release tolterodine or immediate-release oxybutynin: a randomized, placebo-controlled trial

By Homma Y.  

World Journal of Urology, Vol. 22, Iss. 4, 2004-08 ,pp. : 251-256

Springer Publishing Company

Access to resources Recommend Favorite

Pelvic floor electrical stimulation for the treatment of urge and mixed urinary incontinence in women

By Siegel S.W.   Richardson D.A.   Miller K.L.   Karram M.M.   Blackwood N.B.   Sand P.K.   Staskin D.R.   Tuttle J.P.  

Urology, Vol. 50, Iss. 6, 1997-12 ,pp. : 934-940

Elsevier

Access to resources Recommend Favorite